- 1. CA IN SITU BOWEL NEC/NOS
- (UMLS (ICD9CM) C0154065) =Neoplastic Process
| - 22. CA IN SITU SKIN EAR
- [ ] (UMLS (ICD9CM) C0347139) =Neoplastic Process
|
- 2. CA IN SITU BRONCHUS/LUNG
- (UMLS (ICD9CM) C0154071) =Neoplastic Process
| - 23. CA IN SITU SKIN FACE NEC
- (UMLS (ICD9CM) C0154077) =Neoplastic Process
|
- 3. CA IN SITU CERVIX UTERI
- [Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (ICD9CM) C0851140) Carcinoma in situ of Cervix;
Carcinoma in situ of Cervix Uteri; Carcinoma in situ of the Cervix; Carcinoma in situ of the Cervix Uteri; Carcinoma in situ of the Uterine Cervix; Carcinoma in situ of Uterine Cervix; Cervical cancer stage 0; Cervical Carcinoma in situ; Cervical Intraepithelial Neoplasia Grade 3; Cervical Severe More… | - 24. CA IN SITU SKIN LEG
- (UMLS (ICD9CM) C0154081) =Neoplastic Process
|
- 4. CA IN SITU COLON
- [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)-2003 ( NCI )] (UMLS (ICD9CM) C0154061) =Neoplastic Process
| - 25. CA IN SITU SKIN LIP
- (UMLS (ICD9CM) C0154074) =Neoplastic Process
|
- 5. CA IN SITU ESOPHAGUS
- [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (ICD9CM) C0154059) =Neoplastic Process
| - 26. CA IN SITU SKIN NEC
- (UMLS (ICD9CM) C0154082) =Neoplastic Process
|
- 6. CA IN SITU EYE
- [ ] (UMLS (ICD9CM) C0154094) =Neoplastic Process
| - 27. CA IN SITU SKIN NOS
- [Stage 0: Tis: Carcinoma in situ; N0: No regional lymph node metastasis; M0: No distant metastasis. (Based on AJCC Cancer Staging). - 2002 ( NCI )] (UMLS (ICD9CM) C0154073) =Neoplastic Process
|
- 7. CA IN SITU EYELID
- [ ] (UMLS (ICD9CM) C1112527) Carcinoma in situ of eyelid, including canthus =Neoplastic Process
| - 28. CA IN SITU SKIN TRUNK
- (UMLS (ICD9CM) C0154079) =Neoplastic Process
|
- 8. CA IN SITU FEM GEN NEC
- [ ] (UMLS (ICD9CM) C1955739) Carcinoma in situ of other female genital organ;
=Neoplastic Process | - 29. CA IN SITU STOMACH
- [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (ICD9CM) C0154060) =Neoplastic Process
|
- 9. CA IN SITU FEM GEN NOS
- [ ] (UMLS (ICD9CM) C1955737) Carcinoma in situ of unspecified female genital organ;
=Neoplastic Process | - 30. CA IN SITU TRACHEA
- (UMLS (ICD9CM) C0154070) =Neoplastic Process
|
- 10. CA IN SITU GI NEC/NOS
- (UMLS (ICD9CM) C0154067) =Neoplastic Process
| - 31. CA IN SITU URINARY NEC
- [ ] (UMLS (ICD9CM) C0154092) =Neoplastic Process
|
- 11. CA IN SITU LARYNX
- [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)-2003 ( NCI )] (UMLS (ICD9CM) C0154069) =Neoplastic Process
| - 32. CA IN SITU UTERUS NEC
- [ ] (UMLS (ICD9CM) C0154086) =Neoplastic Process
|
- 12. CA IN SITU LIVER/BILIARY
- [ ] (UMLS (ICD9CM) C0496854) =Neoplastic Process
| - 33. Ca44 isotope
- [ ] (UMLS (CSP) C0598043) =Element, Ion, or Isotope ;
|
- 13. CA IN SITU MALE GEN NEC
- [ ] (UMLS (ICD9CM) C0154090) =Neoplastic Process
| - 34. Ca45 isotope
- [ ] (UMLS (CSP) C0303383) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;
|
- 14. CA IN SITU NEC
- (UMLS (ICD9CM) C0007100) =Neoplastic Process ;
| - 35. Ca46 isotope
- [ ] (UMLS (CSP) C0598044) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
|
- 15. CA IN SITU NOS
- [(kar-sin-O-ma in SYE-too) Cancer that involves only the cells in which it began and that has not spread to neighboring tissues. ( NCI )] (UMLS (ICD9CM) C0007099) =Neoplastic Process ;
=carcinoma; =Cervical Dysplasia; PIN | - 36. Ca47 isotope
- [ ] (UMLS (CSP) C0303384) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;
|
- 16. CA IN SITU ORAL CAV/PHAR
- (UMLS (ICD9CM) C0154058) =Neoplastic Process
| - 37. CAI/KCZ
- (UMLS (NCI) C0678016) =Therapeutic or Preventive Procedure
|
- 17. CA IN SITU RECTUM
- [Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ: intraepithelial or invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)-2003 ( NCI )] (UMLS (ICD9CM) C0154062) =Neoplastic Process
| - 38. CAI/Paclitaxel
- (UMLS (NCI) C0281656) =Therapeutic or Preventive Procedure ;
|
- 18. CA IN SITU RESP SYS NEC
- (UMLS (ICD9CM) C0154072) =Neoplastic Process
| - 39. caiman
- [ ] (UMLS (CSP) C0079078) =Reptile
|
- 19. CA IN SITU RESP SYS NOS
- [ ] (UMLS (ICD9CM) C0348402) =Neoplastic Process
| - 40. CAIN
- [Expressed in thymus, spleen, bone marrow, kidney, brain, and testis by human NUP214 Gene (FG-Repeat NUP Family), 2090-aa 214-kDa homodimeric Nuclear Pore Complex Protein NUP214, likely glycosylated, contains F-G repeats and is associated with cytoplasmic filaments and the cytoplasmic face of the nuclear pore complex. NUP214 is required for proper cell cycle progression and, as a nuclear pore component, may regulate nucleocytoplasmic transport by serving as a docking site in receptor-mediated nuclear import. NUP214 interacts with DDX19 and NUP88. Involved in some cases of leukemia, chromosomal translocation t(6;9)(p23;q34) results in a DEK-NUP214 fusion gene, while chromosomal translocation t(6;9)(q21;q34.1) involves a NUP214/SET gene fusion. (NCI) ( NCI )] (UMLS (NCI) C1366674) CAN;
CAN Protein; N214; Nuclear Pore Complex Protein NUP214; Nucleoporin 214kDa; Nucleoporin NUP214; NUP214; p250 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 20. CA IN SITU SCALP
- (UMLS (ICD9CM) C0154078) =Neoplastic Process
| - 41. Cairn Terrier
- [The Cairn Terrier is a hardy little dog with a fox-like expression. It has a compact body with small, pointy and erect ears. It has an abundant shaggy outer coat with a soft downy undercoat. The coat comes in red, brindle, blackish, sand and various shades of gray. Height: 9-13 inches (23-33 cm.) Weight: 13-18 pounds (6-8 kg.) ( NCI )] (UMLS (NCI) C0324329) =Mammal
|
- 21. CA IN SITU SKIN ARM
- (UMLS (ICD9CM) C0154080) =Neoplastic Process
| |